S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China

Neurocrine Biosciences (NBIX) News Today

$132.54
-0.69 (-0.52%)
(As of 04/18/2024 ET)
SourceHeadline
marketbeat.com logoRoman Butler Fullerton & Co. Buys New Holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
marketbeat.com - April 18 at 10:41 AM
insidertrades.com logoInsider Selling: Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Insider Sells 19,818 Shares of Stock
insidertrades.com - April 18 at 6:04 AM
investing.com logoSentia and Neurocrine extend collaboration on peptide therapeutics
investing.com - April 18 at 1:42 AM
marketbeat.com logoEric Benevich Sells 19,818 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Stock
marketbeat.com - April 17 at 6:38 PM
marketbeat.com logoWedbush Reaffirms Outperform Rating for Neurocrine Biosciences (NASDAQ:NBIX)
marketbeat.com - April 17 at 3:51 PM
nasdaq.com logoValidea Detailed Fundamental Analysis - NBIX
nasdaq.com - April 17 at 9:25 AM
marketbeat.com logo12,617 Shares in Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Bought by HealthInvest Partners AB
marketbeat.com - April 16 at 6:50 PM
insidertrades.com logoThe 5 Stocks Most Sold By Insiders This Year (NBIX)
insidertrades.com - April 16 at 10:45 AM
globenewswire.com logoNxera Pharma Notes Successful Development Progress of Partnered Schizophrenia Candidate NBI-1117568
globenewswire.com - April 16 at 2:30 AM
marketbeat.com logoLouisiana State Employees Retirement System Invests $3.64 Million in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
marketbeat.com - April 15 at 7:33 AM
MarketBeat logoNeurocrine Biosciences, Inc. (NASDAQ:NBIX) Receives Average Rating of "Moderate Buy" from Analysts
americanbankingnews.com - April 15 at 2:32 AM
MarketBeat logoResearch Analysts Set Expectations for Neurocrine Biosciences, Inc.'s Q1 2024 Earnings (NASDAQ:NBIX)
americanbankingnews.com - April 13 at 1:46 AM
marketbeat.com logoLeerink Partnrs Comments on Neurocrine Biosciences, Inc.'s Q1 2024 Earnings (NASDAQ:NBIX)
marketbeat.com - April 11 at 7:26 AM
marketbeat.com logoNeurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Bought by Allspring Global Investments Holdings LLC
marketbeat.com - April 11 at 6:58 AM
MarketBeat logoNeurocrine Biosciences' (NBIX) Overweight Rating Reaffirmed at Cantor Fitzgerald
americanbankingnews.com - April 11 at 5:18 AM
prnewswire.com logoNeurocrine Biosciences Announces Conference Call and Webcast of First Quarter 2024 Financial Results
prnewswire.com - April 10 at 4:01 PM
marketbeat.com logoNeurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Sold by Impax Asset Management Group plc
marketbeat.com - April 10 at 10:46 AM
marketbeat.com logoCantor Fitzgerald Reaffirms Overweight Rating for Neurocrine Biosciences (NASDAQ:NBIX)
marketbeat.com - April 10 at 10:25 AM
marketbeat.com logoTobam Lowers Holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
marketbeat.com - April 9 at 11:47 AM
uk.investing.com logoNeurocrine begins phase 2 trial for depression drug
uk.investing.com - April 5 at 4:00 PM
investing.com logoNeurocrine Biosciences executive sells shares worth over $37k
investing.com - April 5 at 4:00 PM
marketbeat.com logoChina Universal Asset Management Co. Ltd. Buys 8,860 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
marketbeat.com - April 4 at 6:54 PM
markets.businessinsider.com logoWells Fargo Reaffirms Their Hold Rating on Neurocrine (NBIX)
markets.businessinsider.com - April 3 at 2:38 PM
finance.yahoo.com logoIs Neurocrine Biosciences, Inc.'s (NASDAQ:NBIX) Recent Performance Tethered To Its Attractive Financial Prospects?
finance.yahoo.com - April 3 at 2:38 PM
prnewswire.com logoNeurocrine Biosciences Announces First-Patient Dosed in Phase 2 Clinical Study Evaluating NBI-1070770 in Adults with Major Depressive Disorder
prnewswire.com - April 3 at 8:30 AM
marketbeat.com logoNeurocrine Biosciences, Inc. (NASDAQ:NBIX) Stock Holdings Reduced by SG Americas Securities LLC
marketbeat.com - April 1 at 4:22 AM
finance.yahoo.com logoNeurocrine Biosciences Announces Initiation of Phase 1 Clinical Study Evaluating Effects of NBI-1065890, a Second-Generation VMAT2 Inhibitor, in Healthy Adults
finance.yahoo.com - March 28 at 8:45 AM
marketbeat.com logoNeurocrine Biosciences (NASDAQ:NBIX) Shares Down 4.4%
marketbeat.com - March 27 at 12:44 PM
marketbeat.com logoAssenagon Asset Management S.A. Lowers Holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
marketbeat.com - March 26 at 2:57 PM
insidertrades.com logoIngrid Delaet Sells 5,000 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Stock
insidertrades.com - March 26 at 4:32 AM
finance.yahoo.com logoS&P 500 Giants Lead Five Stocks Near Buy Points With Fed's Powell A Tailwind
finance.yahoo.com - March 23 at 8:27 AM
marketbeat.com logoRedhawk Wealth Advisors Inc. Takes $1.25 Million Position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
marketbeat.com - March 21 at 10:58 PM
marketbeat.com logoNeurocrine Biosciences (NASDAQ:NBIX) Sets New 52-Week High Following Analyst Upgrade
marketbeat.com - March 21 at 11:51 AM
marketbeat.com logoNeurocrine Biosciences (NASDAQ:NBIX) PT Raised to $158.00
marketbeat.com - March 20 at 8:21 AM
marketbeat.com logoVanguard Group Inc. Sells 10,875 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
marketbeat.com - March 20 at 4:56 AM
marketbeat.com logoNeurocrine Biosciences, Inc. (NASDAQ:NBIX) Holdings Cut by Deutsche Bank AG
marketbeat.com - March 18 at 4:44 AM
uk.investing.com logoNeurocrine Biosciences director sells $5.58m in stock
uk.investing.com - March 17 at 10:32 AM
uk.investing.com logoNeurocrine Biosciences exec sells shares worth over $420k
uk.investing.com - March 17 at 10:32 AM
investing.com logoNeurocrine Biosciences director pops Richard F sells $3.26M in stock
investing.com - March 17 at 10:32 AM
marketbeat.com logoDNB Asset Management AS Has $8.68 Million Stock Holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
marketbeat.com - March 17 at 5:57 AM
insidertrades.com logoGeorge J. Morrow Sells 40,000 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Stock
insidertrades.com - March 17 at 4:22 AM
finance.yahoo.com logoDirector Richard Pops Sells 23,200 Shares of Neurocrine Biosciences Inc (NBIX)
finance.yahoo.com - March 16 at 8:47 AM
finance.yahoo.com logoNeurocrine Biosciences Inc's Chief Regulatory Officer Ingrid Delaet Sells 3,000 Shares
finance.yahoo.com - March 16 at 8:47 AM
finance.yahoo.com logoAI Plays HubSpot, Arista Networks Lead Five Stocks Near Buy Points In Classic Base
finance.yahoo.com - March 16 at 8:47 AM
marketbeat.com logoWalleye Capital LLC Makes New Investment in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
marketbeat.com - March 16 at 4:53 AM
marketbeat.com logoNeurocrine Biosciences, Inc. (NASDAQ:NBIX) Insider Eric Benevich Sells 75,000 Shares
marketbeat.com - March 15 at 7:48 PM
marketbeat.com logoJuncture Wealth Strategies LLC Buys Shares of 8,082 Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
marketbeat.com - March 15 at 7:43 PM
finance.yahoo.com logoNeurocrine Biosciences Is Pioneering Therapies for Neurological Disorders
finance.yahoo.com - March 15 at 2:54 PM
finance.yahoo.com logoNBIX Apr 2024 145.000 call
finance.yahoo.com - March 14 at 8:50 AM
markets.businessinsider.com logoIn-Depth Examination Of 8 Analyst Recommendations For Neurocrine Biosciences
markets.businessinsider.com - March 13 at 8:05 PM
Get Neurocrine Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for NBIX and its competitors with MarketBeat's FREE daily newsletter.

Bitcoin Rockets To Record High But Buy THIS Instead (Ad)

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.

NBIX Media Mentions By Week

NBIX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

NBIX
News Sentiment

0.63

0.49

Average
Medical
News Sentiment

NBIX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

NBIX Articles
This Week

15

8

NBIX Articles
Average Week

Get Neurocrine Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for NBIX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:NBIX) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners